CD19 and acute lymphoblastic leukemia: Relapses occur through either loss of functional CAR T-cell persistence resulting in a CD19-positive relapse, escape from CAR T cells due to antigen loss resulting in a CD19-negative relapse, or more rarely through a lineage switch, especially in infant B-ALL with KMT2A-rearrangement [57].